AASLD Responds to Federal Court Ruling Preserving Hepatitis Vaccine
Alexandria, VA – March 18, 2026 — The American Association for the Study of Liver Diseases (AASLD) supports a recent federal...
AASLD Announces the 2026 Class of Fellows and Associate Fellows
The American Association for the Study of Liver Diseases (AASLD), the leading organization of scientists and health care...
Policy Update from AASLD President Saul J. Karpen & Hepatology Associate Representative, Dawn Drazek
AASLD recently submitted formal comments to the U.S. Department of Education opposing a proposed rule that would exclude nurse...
2027 Spring Emerging Topic Conference: ACLF & Portal Hypertension — From Mechanism to Mastery
Join AASLD for the 2027 Spring Emerging Topic Conference (ETC), where experts will explore the latest advances in acute-on...
Strengthening Collaboration Across Hepatology: All Special Interest Groups Are Now on AASLD SIGnal
AASLD’s Special Interest Groups (SIGs) are where ideas spark, collaborations begin, and advances in hepatology move forward.
We...
2026 AASLD Distinguished Award Nominations Now Open through April 1
AASLD invites nominations to recognize leaders advancing hepatology; recipients will be honored at The Liver Meeting® 2026
ALEX...
A Letter from AASLD President Saul J. Karpen: Elevating Science and Hope This Rare Disease Month
As we recognize Rare Disease Month this February and Rare Disease Day on February 28, I’m reminded that in pediatric hepatology...
Noninvasive Liver Test Performs as Well as Biopsy in Predicting Liver Outcomes in MASLD
ALEXANDRIA, Virginia — A new study in HEPATOLOGY, the premier journal in the field of liver disease, reports that a noninvasive...
AASLD Launches Clinical Informatics and Digital Health Special Interest Group to Advance Innovation in Hepatology
Alexandria, VA — The American Association for the Study of Liver Diseases (AASLD) announced the launch of its new Clinical...